FMP
Theraclion SA
ALTHE.PA
EURONEXT
Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. The company was founded in 2004 and is based in Malakoff, France.
0.362 EUR
0.002 (0.552%)
About
ceo
Mr. Martin Deterre
sector
Healthcare
industry
Medical - Devices
website
https://www.theraclion.com
exchange
EURONEXT
Description
Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. The company was founded in 2004 and is based in Malakoff, France.
CIK
N/A
ISIN
FR0010120402
CUSIP
F9334Q104
Address
102 Rue Etienne Dolet
Phone
33 1 55 48 90 70
Country
FR
Employee
30
IPO Date
Apr 25, 2014
Key Executives
